APHINITY | AACR Cancer Research

APHINITY | AACR Cancer Research

TITLE OF PUBLICATION Effect of young age at diagnosis on clinical outcomes and efficacy of anti-HER2 targeted therapy in patients with HER2-positive early breast cancer: Results from the APHINITY trial Authors Richard D.Gelber; Xin V.Wang; Bernard F.Cole; David...
The HERA Trial: Final Analysis Results

The HERA Trial: Final Analysis Results

Overview The HERceptin Adjuvant (HERA) trial is an adjuvant trial comparing observation vs one year of Herceptin® vs two years of Herceptin® in women with early stage HER2-positive breast cancer. The study was sponsored by Roche. FSS has worked with the Breast...